Zosurabalpin

N/A

Report date: 2026/02/04 11:17:59
NME

Base Information

Drug NameZosurabalpin
Drug Alias NameRO7223280RO-7223280RG-6006
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Synthetic peptide
Mechanisms of ActionLptB2FGC complex inhibitors
TargetsLptB2FGC complex
Therapy Area/IndicationsAcinetobacter InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceIsrael +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche AgF. Hoffmann-La Roche LtdRoche (China) Holding Ltd
Inactive CompaniesN/A
Active IndicationsAcinetobacter InfectionsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A